Nanovation Microtech Ret. on assets
What is the Ret. on assets of Nanovation Microtech?
The Ret. on assets of Nanovation Microtech Inc. is -1,102.13%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Technology sector on OTC compared to Nanovation Microtech
What does Nanovation Microtech do?
Nanovation Microtech, Inc. develops and sells applications and games for iPhone, iPad, and Apple watches. The company was formerly known as Kalmin Corp. and changed its name to Nanovation Microtech, Inc. in July 2020. The company was founded in 2016 and is based in Copenhagen, Denmark. Nanovation Microtech, Inc. is a subsidiary of Greenfield International Limited.
Companies with ret. on assets similar to Nanovation Microtech
- ProVenture Capital has Ret. on assets of -1,398.46%
- Unex has Ret. on assets of -1,278.36%
- Pressure BioSciences has Ret. on assets of -1,272.80%
- Maitri Health Technologies has Ret. on assets of -1,200.33%
- Scopus Biopharma has Ret. on assets of -1,195.79%
- Solei Systems has Ret. on assets of -1,153.04%
- Nanovation Microtech has Ret. on assets of -1,102.13%
- Banjo & Matilda has Ret. on assets of -962.76%
- Biosig Technologies Inc has Ret. on assets of -948.39%
- Alliance Mining has Ret. on assets of -889.27%
- InsuraGuest Technologies has Ret. on assets of -884.37%
- Vitalibis has Ret. on assets of -870.33%
- Zelira Therapeutics has Ret. on assets of -869.92%